Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer

NCT00824161 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: TAS-109

Sponsor

Taiho Pharmaceutical Co., Ltd.